[1] |
Lyu Ling, Lyu Xiaoyan.
Dermatomyositis with malignancy: an update
[J]. Chinese Journal of Dermatology, 2022, 55(3): 276-279.
|
[2] |
Autoimmune Disease Group, China Dermatologist Association.
Chinese expert consensus on cyclophosphamide for the treatment of autoimmune dermatoses
[J]. Chinese Journal of Dermatology, 2021, 54(9): 765-770.
|
[3] |
Yang Changzhi, Zhang Xiaoping, Yang Ziliang, Zhou Naihui, Zhu Liping, Shao Kai, Zhu Tingting, Yu Xiuqin.
Association of antinuclear antibody status with clinical features and malignancy risk in adult patients with dermatomyositis
[J]. Chinese Journal of Dermatology, 2021, 54(6): 480-484.
|
[4] |
Hua Weiwei, Gong Chunyan.
Application of JAK inhibitors in the treatment of refractory dermatomyositis
[J]. Chinese Journal of Dermatology, 2021, 54(3): 264-267.
|
[5] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Azathioprine in the treatment of immune?related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2021, 54(2): 116-121.
|
[6] |
Zhang Shimin, Hu Yunyun, Zhao Xiaoqing, Du Lianjun, Cao Hua, Zheng Jie.
Application of imaging techniques in diagnosis and severity assessment of dermatomyositis
[J]. Chinese Journal of Dermatology, 2021, 0(1): 20200447-e20200447.
|
[7] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Mycophenolate mofetil in the treatment of immune?related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2020, 53(11): 869-874.
|
[8] |
Xue Ke, Quan Cheng, Zhao Qian, Diao Licheng, Chen Mengya, Zhu Xuemei, Zheng Jie, Cao Hua, Li Hao .
Differentially expressed genes in peripheral blood of patients with dermatomyositis complicated by interstitial lung disease or malignant tumors
[J]. Chinese Journal of Dermatology, 2020, 53(1): 23-29.
|
[9] |
Zhu Xueqing, Xue Ke, Ruan Yeping, Diao Licheng, Zhao Xiaoqing, Du Lianjun, Li Hao, Cao Hua, Zheng Jie.
Clinical features of anti-signal recognition particle antibody-positive patients with dermatomyositis or clinically amyopathic dermatomyositis
[J]. Chinese Journal of Dermatology, 2019, 52(11): 796-800.
|
[10] |
Lu Jinghao, Liu Chaofan, Zhou Xing, Hu Dongyan, Xin Chongmei, Zhu Lubing, Li Ming.
Clinical analysis of four cases of dermatomyositis with painful palmar eruptions complicated by fatal rapidly progressive interstitial lung disease
[J]. Chinese Journal of Dermatology, 2018, 51(8): 564-568.
|
[11] |
Lu Jinghao, Zhou Xing, Liu Chaofan, Zhu Lubing, Li Ming.
Correlation between dermatomyositis rashes and interstitial lung disease
[J]. Chinese Journal of Dermatology, 2018, 51(10): 779-781.
|
[12] |
.
Detection of serum cytokines in patients with dermatomyositis and their clinical significance
[J]. Chinese Journal of Dermatology, 2018, 51(1): 34-38.
|
[13] |
.
Detection of anti-CADM-140 antibody in patients with dermatomyositis or clinically amyopathic dermatomyositis and its clinical significance
[J]. Chinese Journal of Dermatology, 2011, 44(7): 461-464.
|
[14] |
Wu wei .
Detection of CD4+CD25+DC127lo/- regulatory T cells in patients with active dermatomyositis
[J]. Chinese Journal of Dermatology, 2009, 42(1): 55-56.
|
[15] |
.
Gottron papules and interstitial lung disease in patients with dermatomyositis
[J]. Chinese Journal of Dermatology, 2009, 42(1): 19-21.
|